Literature DB >> 18371131

Racial differences in liver transplantation outcomes in the MELD era.

Ashwin N Ananthakrishnan1, Kia Saeian.   

Abstract

OBJECTIVES: Beginning February 28, 2002, the Model for End-Stage Liver Disease (MELD) score was introduced to better allocate donor livers. Racial differences in orthotopic liver transplantation (OLT) outcomes prior to this time have been attributed to late listing of some racial groups. Racial differences in post-transplant survival in the MELD era have not been previously examined.
METHODS: We performed a retrospective observational cohort study using the United Network for Organ Sharing database for adult liver transplants performed between 2002 and 2006. We examined patient and graft survival at 2 yr and compared disease-specific survival rates among the different races.
RESULTS: A total of 10,409 whites, 1,133 blacks, 1,548 Hispanics, and 765 transplant recipients belonging to other races were included in the study. On multivariate analysis, blacks had lower overall (hazard ratio for death [HR] 1.29, 95% confidence interval [95% CI] 1.10-1.52) and graft (HR 1.38, 95% CI 1.20-1.58) survival at 2 yr compared to whites, while Hispanics had better overall (HR 0.78) and graft (HR 0.82) survival. Compared to whites, blacks transplanted for hepatitis C or HCC had lower survival at 2 yr.
CONCLUSION: In the MELD era, black patients have significantly lower overall and graft survival at 2 yr compared to whites.

Entities:  

Mesh:

Year:  2008        PMID: 18371131     DOI: 10.1111/j.1572-0241.2008.01809.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  29 in total

1.  Impact of donor and recipient race on survival after hepatitis C-related liver transplantation.

Authors:  Jennifer E Layden; Scott J Cotler; Shellee A Grim; Michael J Fischer; Michael R Lucey; Nina M Clark
Journal:  Transplantation       Date:  2012-02-27       Impact factor: 4.939

2.  Racial and Ethnic Differences in Graft Loss Among Female Liver Transplant Recipients.

Authors:  S Dave; J L Dodge; N A Terrault; M Sarkar
Journal:  Transplant Proc       Date:  2018-06       Impact factor: 1.066

3.  Ethnic disparities in liver transplantation.

Authors:  Nyingi Kemmer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

4.  Racial differences in fibrosis progression after HCV-related liver transplantation.

Authors:  Jennifer E Layden; Scott Cotler; Kimberly A Brown; Michael R Lucey; Helen S Te; Sheila Eswaran; Claus Fimmel; Thomas J Layden; Nina M Clark
Journal:  Transplantation       Date:  2012-07-27       Impact factor: 4.939

5.  Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma.

Authors:  Jeanette C Yu; Alfred I Neugut; Shuang Wang; Judith S Jacobson; Lauren Ferrante; Vandana Khungar; Emerson Lim; Dawn L Hershman; Robert S Brown; Abby B Siegel
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

Review 6.  Race and ethnicity in access to and outcomes of liver transplantation: a critical literature review.

Authors:  A K Mathur; C J Sonnenday; R M Merion
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

Review 7.  Chronic liver disease in the Hispanic population of the United States.

Authors:  Andres F Carrion; Ravi Ghanta; Olveen Carrasquillo; Paul Martin
Journal:  Clin Gastroenterol Hepatol       Date:  2011-05-12       Impact factor: 11.382

8.  Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.

Authors:  Elizabeth C Verna; Rosa Valadao; Erica Farrand; Elsa M Pichardo; Jennifer C Lai; Norah A Terrault; Robert S Brown
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

9.  Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C.

Authors:  Jennifer E Layden; Bamidele O Tayo; Scott J Cotler; Nina M Clark; Kristine Baraoidan; Scott L Friedman; Richard S Cooper
Journal:  Transplantation       Date:  2014-05-27       Impact factor: 4.939

10.  Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.

Authors:  Robert J Wong; Douglas A Corley
Journal:  Dig Dis Sci       Date:  2009-01-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.